Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Board member of FluoGuide sells some of his shares to pay capital gain tax on his shareholding

Copenhagen, Denmark, 29 December 2020 - FluoGuide A/S (“FluoGuide” or “the Company”) board member Peter Mørch Eriksen has, through his company PME Consult ApS, sold 14,000 shares in FluoGuide on 29 December 2020 to pay capital gain tax on his shareholding in FluoGuide under Danish tax regulations. Peter Mørch Eriksen is an active and committed Board member and with a long-term interest in the Company. After the transaction, Peter Mørch Eriksen owns 117,297 shares in FluoGuide through his company PME Consult ApS, corresponding to 1.1 percent of the shares and votes in the Company.“Due to

#20-467 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-466 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Konecranes signs Science Based Targets Initiative (SBTi) commitment to mitigate climate change

Konecranes today announced it has signed the commitment letter for the Science Based Targets Initiative (SBTi) and will define new climate targets for its operations in the coming months, reinforcing its commitment to cut emissions, further develop its low-carbon portfolio and mitigate climate risks.Limiting global warming requires the decarbonization of all industry sectors. By committing to science-based targets, Konecranes is stepping up efforts to reduce its climate impact. The company is already charting the full carbon footprint from its own operations and supply chain as well as

I-Tech signs U.S. leisure boat collaboration agreement

  I-Tech AB (publ) (ticker: ITECH) has signed a long-term collaboration agreement with Pettit Marine Paint, a supplier of high-performance antifouling paints to the leisure boat markets in North, Central, and South America. Through the collaboration, both parties will work together to develop a new product line of antifouling paints for leisure boats that make use of I-Tech’s barnacle repelling active agent, Selektope®. Joint investments will include R&D activities, achieving regulatory approval from the United States (U.S) Environmental Protection Agency (EPA) and

Vestas develops 4 MW platform solution for wind project in complex terrain in northern Italy

News release from Vestas MediterraneanMadrid, 29 December 2020 Gruppo FERA, through its subsidiary Aleramo Srl, has placed a 20 MW order for the Cairo Montenotte wind project, located in Cascinassa, Liguria, in northern Italy. Vestas will supply, transport, install and commission five V136-4.2 MW wind turbines delivered in 4.0 operating mode, as well as an 18-years Active Output Management 5000 (AOM 5000) service agreement. With the project located in complex mountainous terrain with little space to move larger rotor turbine components, the order demonstrates how Vestas can leverage

Altia’s financial reporting and Annual General Meeting in 2021

Altia Plc   Stock Exchange Release   29 December 2020 at 2:30 pm EET Altia’s financial reporting and Annual General Meeting in 2021 Altia Plc will publish the financial statements bulletin, half-year report and two business reviews in 2021 as follows: 25 February 2021: Financial Statements Bulletin for 2020 28 April 2021: Business Review for January-March 2021 18 August 2021: Half-Year Report for January-June 2021 3 November 2021: Business Review for January-September 2021 Altia applies a silent period of 30 days before the publication of financial reports. The

Extraordinary General Meeting in Haldex AB

On Tuesday, 29 December 2020, Haldex AB (publ) held an Extraordinary General Meeting. Due to Covid-19, the Extraordinary General Meeting was held without any physical presence and shareholders were able to exercise their voting rights only by digital voting in advance (postal voting). The General Meeting resolved to elect two additional board members to the Board of Directors.The General Meeting resolved to approve of the joint proposal by AFA Sjukförsäkrings AB, AMF Pensionsförsäkring AB, Athanase Industrial Partner and Fjärde AP-fonden to appoint Detlef Borghardt and Dzeki Mackinovski as

CEO Henrik Norström takes time out from his assignment – Christer Trägårdh becomes acting CEO

This is an English translation of previously announced information on 23 December and 28 December, that was only published in Swedish. Following the information published  on Wednesday 23 December regarding Brighter’s CEO Henrik Norström being under investigation of the Swedish Economic Crime Authority for market abuse in the securities market, Henrik has decided to take a time out from his assignment as CEO. The decision has been made in consultation with the Board. Henrik denies the

Letter of intent regarding Östermalmshallen

Wallenstam has signed a letter of intent with the City of Stockholm regarding the building, which has been used for the evacuation of Östermalmshallen. The building, which is located at Östermalmstorg, opened in 2016 when the regular market hall was to be renovated, and it closed for good on February 15, 2020.The letter of intent means that the City of Stockholm and Wallenstam will jointly work for a conveyance of the market hall through a purchase agreement and that Wallenstam will be given the exclusive right to negotiate with the City about the purchase up to and including February 1,

Carnegie ranked number one  in the Nordics for Domestic Equity.

For the fourth consecutive year, Carnegie tops the rankings in Nordic equity research, equity sales and corporate access. This is according to the Kantar Sifo Prospera annual market survey in which institutional investors evaluate Nordic research and brokerage houses.Carnegie is held in the highest regard for research and brokerage services in the Nordic market, according to the Kantar Sifo Prospera annual customer survey, in which around 172 institutional investors evaluate Nordic market providers. It’s the fourth year in a row Carnegie tops both the overall ranking and all evaluated

Shaikan Payment Update

29 December 2020 Gulf Keystone Petroleum Ltd. (LSE: GKP) ("Gulf Keystone", "GKP" or "the Company") Shaikan Payment Update   Gulf Keystone confirms that a gross payment of $10.9 million ($8.6 million net to GKP) has been received from the Kurdistan Regional Government ("KRG") for Shaikan crude oil sales during November 2020.  This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.   Enquiries: Celicourt Communications: + 44(0) 20 8434 2754Mark AntelmeJimmy Lea   or visit: www.gulfkeystone.com Notes

Eficode positioned as a Rising Star in the ISG Provider Lens™ Report on Public Cloud – Solutions & Services

Eficode recognized by  ISG for its “promising portfolio” and “high future potential”.Helsinki, Finland, 23 December 2020 -- Eficode, Europe’s leading DevOps company has been recognized by ISG (Information Services Group), a leading global technology research and advisory firm, as a Rising Star for Public Cloud – Solutions & Services in the Nordic region , in their 2020 ISG Provider Lens™ Quadrant  report.[Rising star recognition badge by ISG] The Rising star recognition is given by ISG for companies with a promising portfolio and high

Read original

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 129 -29 DECEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Glaston Corporation: Notification of Change in Holdings according to Chapter 9, Section 10 of the Securities Markets Act

Glaston Corporation    Stock Exchange Release       29.12.2020 at 10.30Glaston Corporation has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Ahlström Capital Oy, according to which as a result of an intragroup merger in which AC Invest Eight B.V. has been merged into its parent company Ahlstrom Capital B.V., Ahlstrom Capital B.V. is therefore as of 28 December 2020 the direct shareholder in Glaston Oyj Abp.Total position of person subject to the notification obligation: % of shares % of shares and Total of Total

EXTENSION OF AND CHANGES TO THE COMMITTED AMOUNTS OF DELETE’S REVOLVING CREDIT FACILITY

Delete Group Oyj | Stock Exchange Release 29 December 2020 at 10:15 a.m. (EET)The Delete Group’s committed revolving credit facility (RCF) with Nordea Bank Abp (the "Nordea RCF") has been extended until 15 February 2021 with the following changes to the committed amounts: · EUR 12,000,000 from 16 December 2020 to and including 31 December 2020; · EUR 9,000,000 from 1 January 2021 to and including 15 January 2021; and · EUR 7,000,000 from 16 January 2021 to and including 15 February 2021. The committed RCF amount was immediately prior to the agreed changes EUR 15,000,00 and the

Container Terminal St. Petersburg orders 2 STS cranes from Konecranes

Container Terminal St. Petersburg (CTSP) has ordered two Konecranes Ship-to-Shore cranes, continuing a relationship that dates back to 2008. When the new cranes are in service, CTSP will operate a fleet of 6 Konecranes STSs and 24 Konecranes RTGs. The order was booked in December 2020. CTSP will receive the cranes in Q1-Q2 of 2022. They will have the size and outreach to handle container ships with 16 container rows across.Mr Aleksandr Scherbinin, Managing Director of CTSP said: “We have been using Konecranes container cranes for a long time, and we have always been satisfied with the

Nokian Tyres introduces new flagship products for its winter tire range: NOKIAN HAKKAPELIITTA® 10 utilizes the industry’s latest stud technology

Nokian Tyres  is renewing its comprehensive and versatile range of studded tires. At the beginning of 2021, the world's northernmost tire manufacturer is introducing its new flagship products: the Nokian Hakkapeliitta 10 studded tires for passenger cars and SUVs. A special new introduction into this product family is a dedicated version for electric vehicles and hybrids. For the first time, Nokian Tyres is also introducing a model especially tailored for the Russian market: the Nokian Hakkapeliitta 10p studded tire. - Nokian Hakkapeliitta winter tires are

Alligator Bioscience recruits new Chief Medical Officer

Lund, Sweden, December 29, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina Reimer as Chief Medical Officer. She most recently comes from a position as Senior Medical Director at Ferring Pharmaceuticals in Copenhagen. Dr Reimer will replace Dr Charlotte Russel and be overall medically responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies.  She will report to Head of R&D, EVP Malin Carlsson, and be part of the management team. “I am

The Election Committee in Castellum

Castellum has received additional information regarding the proposal from the Election CommitteeThe members of the Election Committee Vincent Fokke, representing Stichting Pensioenfonds ABP, and Charlotte Strömberg, Chair of the Board in Castellum, have notified Castellum that they have additional information in relation to the Election Committee’s proposal as regards nomination of the Chairman of the Board in Castellum that they believe are of importance to the shareholders of the company. Statement by Vincent Fokke and Charlotte Strömberg: We do not support the proposal to nominate

Supplementary analyses to topline Phase II results reveal additional RP101 clinical strengths

· RP101 demonstrates treatment difference versus control (Intelligel vehicle) in inferior corneal staining with robust and significant improvement · SANDE symptom score also reveals significant treatment difference versus control in a subgroup of more severe patients · Both inferior corneal staining and SANDE endpoints have been accepted by the US FDA for clinical endpoints in other dry eye programs · RP101 is well-positioned for continued development in a larger pivotal clinical trial (December 29, 2020, Stockholm, Sweden) - After publishing topline Phase II results of the RP101

Lynparza approved in Japan for three cancers

29 December 2020 07:00 GMT Lynparza approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers Approvals based on the PAOLA-1, PROfound and POLO Phase III trials AstraZeneca and MSD's Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers. The three approvals authorise Lynparza for: maintenance treatment after 1st-line chemotherapy containing bevacizumab (genetical recombination) for patients with homologous recombination repair deficient (HRD) ovarian cancer; the treatment of patients

There are no items matching the current filter
There are no more items matching the current filter
Back to top